Cargando…

Determinants of Mouse Hepatitis Virus 3C-like Proteinase Activity

The coronavirus, mouse hepatitis virus strain A59 (MHV), expresses a chymotrypsin-like cysteine proteinase (3CLpro) within the gene 1 polyprotein. The MHV 3CLpro is similar to the picornavirus 3C proteinases in the relative location of confirmed catalytic histidine and cysteine residues and in the p...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Yiqi, Denison, Mark R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academic Press. 1997
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131224/
https://www.ncbi.nlm.nih.gov/pubmed/9143289
http://dx.doi.org/10.1006/viro.1997.8479
_version_ 1783517190008340480
author Lu, Yiqi
Denison, Mark R.
author_facet Lu, Yiqi
Denison, Mark R.
author_sort Lu, Yiqi
collection PubMed
description The coronavirus, mouse hepatitis virus strain A59 (MHV), expresses a chymotrypsin-like cysteine proteinase (3CLpro) within the gene 1 polyprotein. The MHV 3CLpro is similar to the picornavirus 3C proteinases in the relative location of confirmed catalytic histidine and cysteine residues and in the predicted use of Q/(S, A, G) dipeptide cleavage sites. However, less is known concerning the participation of aspartic acid or glutamic acid residues in catalysis by the coronavirus 3C-like proteinases or of the precise coding sequence of 3CLpro within the gene 1 polyprotein. In this study, aspartic acid residues in MHV 3CLpro were mutated and the mutant proteinases were tested for activity in anin vitro transcleavage assay. MHV 3CLpro was not inactivated by substitutions at Asp(3386)(D53) or Asp(3398)(D65), demonstrating that they were not catalytic residues. MHV 3CLpro was able to cleave at a glutamine–glycine (QG(3607-8)) dipeptide within the 3CLpro domain upstream from the predicted carboxy-terminal QS(3635-6)cleavage site of 3CLpro. The predicted full-length 3CLpro (S(3334)to Q(3635)) had an apparent mass of 27 kDa, identical to the p27 3CLpro in cells, whereas the truncated proteinase (S(3334)to Q(3607)) had an apparent mass of 24 kDa. This 28-amino-acid carboxy-terminal truncation of 3CLpro rendered it inactive in atranscleavage assay. Thus, MHV 3CLpro was able to cleave at a site within the putative full-length proteinase, but the entire predicted 3CLpro domain was required for activity. These studies suggest that the coronavirus 3CL-proteinases may have a substantially different structure and catalytic mechanism than other 3C-like proteinases.
format Online
Article
Text
id pubmed-7131224
institution National Center for Biotechnology Information
language English
publishDate 1997
publisher Academic Press.
record_format MEDLINE/PubMed
spelling pubmed-71312242020-04-08 Determinants of Mouse Hepatitis Virus 3C-like Proteinase Activity Lu, Yiqi Denison, Mark R. Virology Regular Article The coronavirus, mouse hepatitis virus strain A59 (MHV), expresses a chymotrypsin-like cysteine proteinase (3CLpro) within the gene 1 polyprotein. The MHV 3CLpro is similar to the picornavirus 3C proteinases in the relative location of confirmed catalytic histidine and cysteine residues and in the predicted use of Q/(S, A, G) dipeptide cleavage sites. However, less is known concerning the participation of aspartic acid or glutamic acid residues in catalysis by the coronavirus 3C-like proteinases or of the precise coding sequence of 3CLpro within the gene 1 polyprotein. In this study, aspartic acid residues in MHV 3CLpro were mutated and the mutant proteinases were tested for activity in anin vitro transcleavage assay. MHV 3CLpro was not inactivated by substitutions at Asp(3386)(D53) or Asp(3398)(D65), demonstrating that they were not catalytic residues. MHV 3CLpro was able to cleave at a glutamine–glycine (QG(3607-8)) dipeptide within the 3CLpro domain upstream from the predicted carboxy-terminal QS(3635-6)cleavage site of 3CLpro. The predicted full-length 3CLpro (S(3334)to Q(3635)) had an apparent mass of 27 kDa, identical to the p27 3CLpro in cells, whereas the truncated proteinase (S(3334)to Q(3607)) had an apparent mass of 24 kDa. This 28-amino-acid carboxy-terminal truncation of 3CLpro rendered it inactive in atranscleavage assay. Thus, MHV 3CLpro was able to cleave at a site within the putative full-length proteinase, but the entire predicted 3CLpro domain was required for activity. These studies suggest that the coronavirus 3CL-proteinases may have a substantially different structure and catalytic mechanism than other 3C-like proteinases. Academic Press. 1997-04-14 2002-05-25 /pmc/articles/PMC7131224/ /pubmed/9143289 http://dx.doi.org/10.1006/viro.1997.8479 Text en Copyright © 1997 Academic Press. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Regular Article
Lu, Yiqi
Denison, Mark R.
Determinants of Mouse Hepatitis Virus 3C-like Proteinase Activity
title Determinants of Mouse Hepatitis Virus 3C-like Proteinase Activity
title_full Determinants of Mouse Hepatitis Virus 3C-like Proteinase Activity
title_fullStr Determinants of Mouse Hepatitis Virus 3C-like Proteinase Activity
title_full_unstemmed Determinants of Mouse Hepatitis Virus 3C-like Proteinase Activity
title_short Determinants of Mouse Hepatitis Virus 3C-like Proteinase Activity
title_sort determinants of mouse hepatitis virus 3c-like proteinase activity
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7131224/
https://www.ncbi.nlm.nih.gov/pubmed/9143289
http://dx.doi.org/10.1006/viro.1997.8479
work_keys_str_mv AT luyiqi determinantsofmousehepatitisvirus3clikeproteinaseactivity
AT denisonmarkr determinantsofmousehepatitisvirus3clikeproteinaseactivity